发明名称 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
摘要 The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like.;The present invention relates to a compound represented by the formula (I) or a salt thereof.;;wherein each symbol is as described in the specification, or a salt thereof.
申请公布号 US2017100373(A1) 申请公布日期 2017.04.13
申请号 US201615388834 申请日期 2016.12.22
申请人 Takeda Pharmaceutical Company Limited 发明人 YAMADA Masami;SUZUKI Shinkichi;SUGIMOTO Takahiro;NAKAMURA Minoru;SAKAMOTO Hiroki;KAMATA Makoto
分类号 A61K31/4035 主分类号 A61K31/4035
代理机构 代理人
主权项
地址 Osaka JP